Robert McNeil - Profile and Investment Details

Investor Profile

Robert McNeil is a Venture Capital, Private Equity Firm, Micro VC based in San Mateo, California, United States with a diverse investment portfolio that includes companies such as Chimerix, Taligen Therapeutics, CalciMedica, SpecificiT Pharma, GentericNovoStent Corporation, Naviscan, Sotera Wireless, Asteres, Aderis Pharmaceuticals, Kadmus Pharmaceuticals, Alteer, CyThera, CoMentis, Xytis, Tomophase, Zapaq, ViaCyte, CardioNet, PreciThera, Ista Pharmaceuticals, Endocyte, Cylene Pharmaceuticals, Metavention, Lineagen, Torax Medical, DalCor Pharmaceuticals, Dynavax Technologies, Neomend, Axikin Pharmaceuticals, TheraVida, Artielle ImmunoTherapeutics, Net32, InfraReDx, Glycomine, Altor BioScience, Gemin X Pharmaceuticals, Trinity Biosystems, Actimis Pharmaceuticals, . Over time, Robert McNeil has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Robert McNeil is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Women Founded, Life Science, Information Technology (IT), Biotechnology, Medical, Media and Entertainment may find it worthwhile to explore potential connections with Robert McNeil, as their portfolio suggests a familiarity and interest in this area.

Understanding Robert McNeil’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.